385 related articles for article (PubMed ID: 24225342)
41. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
[TBL] [Abstract][Full Text] [Related]
42. MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study.
De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Dos Santos MS; Rutteman GR; Gärtner Mde F
Anticancer Res; 2006; 26(3A):1821-6. PubMed ID: 16827113
[TBL] [Abstract][Full Text] [Related]
43. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables.
Matos AJ; Lopes C; Carvalheira J; Santos M; Rutteman GR; Gärtner F
J Comp Pathol; 2006; 134(2-3):182-9. PubMed ID: 16545841
[TBL] [Abstract][Full Text] [Related]
44. Decorin concentrations in canine normal and neoplastic mammary gland tissues.
Szczubiał M; Kankofer M; Wawrzykowski J; Dąbrowski R; Łopuszyński W; Bochniarz M; Brodzki P
Reprod Domest Anim; 2020 Oct; 55(10):1404-1410. PubMed ID: 33470009
[TBL] [Abstract][Full Text] [Related]
45. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
46. Changes in serum neopterin and C-reactive protein concentrations in female dogs with mammary gland tumours.
Szczubiał M; Dabrowski R; Łopuszyński W; Bochniarz M; Krawczyk M
Pol J Vet Sci; 2018 Dec; 21(4):691-696. PubMed ID: 30605283
[TBL] [Abstract][Full Text] [Related]
47. A low frequency of lymph node metastasis in clear-cell renal cell carcinoma is related to low lymphangiogenic activity.
Baldewijns MM; Roskams T; Ballet V; Van den Eynden GG; Van Laere SJ; Van der Auwera I; Lerut E; De Bruïne AP; Thijssen VL; Vermeulen PB; van Poppel H
BJU Int; 2009 Jun; 103(12):1626-31. PubMed ID: 19154467
[TBL] [Abstract][Full Text] [Related]
48. CD117 expression influences proliferation but not survival in canine mammary tumours.
Brunetti B; Beha G; Benazzi C; Bondin V; De Tolla L; Sarli G
J Comp Pathol; 2014; 151(2-3):202-6. PubMed ID: 25027114
[TBL] [Abstract][Full Text] [Related]
49. CD204-Expressing Tumor-Associated Macrophages Are Associated With Malignant, High-Grade, and Hormone Receptor-Negative Canine Mammary Gland Tumors.
Seung BJ; Lim HY; Shin JI; Kim HW; Cho SH; Kim SH; Sur JH
Vet Pathol; 2018 May; 55(3):417-424. PubMed ID: 29343199
[TBL] [Abstract][Full Text] [Related]
50. Analysis of Hypoxia-Inducible Factor-1α Expression Relative to Other Key Factors in Malignant Canine Mammary Tumours.
Shin JI; Lim HY; Kim HW; Seung BJ; Sur JH
J Comp Pathol; 2015; 153(2-3):101-10. PubMed ID: 26145724
[TBL] [Abstract][Full Text] [Related]
51. Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation.
Andreasen EB; Nielsen OL; Tranholm M; Knudsen T; Kristensen AT
Vet Comp Oncol; 2016 Jun; 14(2):191-201. PubMed ID: 24674618
[TBL] [Abstract][Full Text] [Related]
52. Use of CD10 as a marker of canine mammary myoepithelial cells.
Sánchez-Céspedes R; Suárez-Bonnet A; Millán Y; Guil-Luna S; Reymundo C; Herráez P; Espinosa de Los Monteros A; Martin de Las Mulas J
Vet J; 2013 Feb; 195(2):192-9. PubMed ID: 22819182
[TBL] [Abstract][Full Text] [Related]
53. Quantification of VEGF-C expression in canine mammary tumours.
Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
[TBL] [Abstract][Full Text] [Related]
54. First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases.
Pérez-Alenza MD; Jiménez A; Nieto AI; Peña L
Breast Cancer Res; 2004; 6(4):R300-7. PubMed ID: 15217496
[TBL] [Abstract][Full Text] [Related]
55. The role of CD44 adhesion factor in canine mammary carcinomas.
Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
[TBL] [Abstract][Full Text] [Related]
56. Heat shock protein expression in canine malignant mammary tumours.
Romanucci M; Marinelli A; Sarli G; Della Salda L
BMC Cancer; 2006 Jun; 6():171. PubMed ID: 16803633
[TBL] [Abstract][Full Text] [Related]
57. Canine invasive lobular carcinoma of the mammary gland: morphological and immunohistochemical characterizations of three cases.
Ressel L; Millanta F; Poli A
J Comp Pathol; 2011 May; 144(4):303-7. PubMed ID: 20961557
[TBL] [Abstract][Full Text] [Related]
58. Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers.
Kim NH; Lim HY; Im KS; Kim JH; Sur JH
J Comp Pathol; 2013 May; 148(4):298-306. PubMed ID: 23079102
[TBL] [Abstract][Full Text] [Related]
59. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
[TBL] [Abstract][Full Text] [Related]
60. Myoepithelial cell layer integrity in canine mammary carcinoma.
Sánchez-Céspedes R; Millán Y; Guil-Luna S; García-Monterde J; Reymundo C; Espinosa de los Monteros A; Martín de las Mulas J
J Comp Pathol; 2011 Jul; 145(1):25-30. PubMed ID: 21247585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
